Impact Factor
3.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.46
542 total citations
h5-index
31
h5 depth signal
Cited share
89.0%
97 of 109
Total citations
542
Citation footprint
Metric signal
6.38
External metric anchor
Self-citation
1.1%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
240
United Kingdom
58
Germany
54
Italy
44
Netherlands
35
Citing Fields of Research
Cardiology
431
Kidney Diseases
25
Cancer Drugs
22
Auto-Inflammatory Disorders
18
Diabetes
18
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
976
Articles tracked across the journal lifetime
Indexed publication set
109
97 cited publications
Last 12 months
64
5.3 publications/month
Open access share
46.9%
30 OA publications in the last year
Leading citing country
United States
240 citing publications
Leading citing field
Cardiology
431 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Apr.-May 2004-
v1n1, Apr.-May 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Cardiology
MeSH Descriptors
Heart Failure
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s11897-026-00783-8
Open DOI
Personalized Remote Patient Management in Heart Failure
Purpose of Review: Implanted pulmonary artery pressure (PAP) monitoring provides an early window on imminent worsening heart failure (HF). Randomized trials demonstrated that PAP-guided management significantly reduces HF hospitalization...
02
DOI 10.1007/s11897-026-00784-7
Open DOI
Precision Immunosuppression in Heart Transplantation: Biomarker-Guided Therapy Comes of Age
Purpose of Review: Heart transplantation is the definitive treatment for end-stage heart failure. While the number of heart transplant performed yearly in the United States has nearly doubled in the last decade, median survival has stagn...
03
DOI 10.1007/s11897-026-00779-4
Open DOI
Clonal Hematopoiesis and Inflammatory Pathways in Heart Failure with Preserved Ejection Fraction
Purpose of Review: This review aims to examine the role of clonal hematopoiesis of indeterminate potential (CHIP) in the pathophysiology of heart failure with preserved ejection fraction (HFpEF), focusing on its contribution to inflammat...
04
DOI 10.1007/s11897-026-00778-5
Open DOI
The Future of Cardiac Care: A Review on the Role for Non-Invasive, Home-Based Monitoring and Rehabilitation after Hospitalisation for Acute Decompensated Heart Failure
Purpose of Review: Heart failure (HF) is characterised by recurrent decompensation leading to worsening of symptoms and unplanned hospitalisations. Patients often experience poor post-hospitalisation recovery, fail to maintain functional...
05
DOI 10.1007/s11897-026-00780-x
Open DOI
Exercise, Nutrition and GLP-1 Medicines to Improve Body Weight and Muscle Function in Heart Failure with Preserved Ejection Fraction
Purpose of Review: This narrative review synthesizes current evidence on lifestyle, pharmacological, surgical, and multimodal interventions targeting muscle strength, body composition, and functional capacity in HFpEF with sarcopenia and...
06
DOI 10.1007/s11897-026-00777-6
Open DOI
Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results?
Purpose of Review: The management of end-stage heart failure in cardiac amyloidosis due to both light chain (AL-CA) and transthyretin (ATTR-CA) with heart transplantation has historically been limited by concerns about systemic progressi...
07
DOI 10.1007/s11897-026-00771-y
Open DOI
Opioid Use for Dyspnoea in Advanced Heart Failure
Purpose of review This narrative review aims to provide an overview of the available evidence on opioid use for refractory dyspnoea in advanced heart failure, focusing on mechanisms, effectiveness, safety, patient selection, and their po...
08
DOI 10.1007/s11897-026-00776-7
Open DOI
Managing Cardiogenic Shock in the Era of Multimodal Mechanical Support: Bridging to Transplant or Recovery
Purpose of Review To review the contemporary management of cardiogenic shock in the era of multimodal temporary mechanical circulatory support, with emphasis on phenotype-guided device selection, serial trajectory assessment, and bridgin...
09
DOI 10.1007/s11897-026-00775-8
Open DOI
Endomyocardial Biopsies in the Diagnostic Workup of Immune Checkpoint Inhibitor Associated Myocarditis
10
DOI 10.1007/s11897-026-00772-x
Open DOI
Deactivation of Cardiac Devices at the End of Life: Clinical and Ethical Challenges
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 4, no. 4 (Dec. 2007)
Also issued online.
v. 1, no. 1 (Mar. 2004)20050727 Notice published Printed on acid-free paper